Last reviewed · How we verify

NCT03537885

EEG Analytics to Determine Effectiveness of a tDCS Protocol

Completed NA Last updated 6 August 2024
What this trial tests

NA trial testing Transcranial Direct Current Stimulation in Healthy in 27 participants. Completed in 31 December 2018.

Timeline
1 February 2015
Primary endpoint
27 June 2018
31 December 2018

Quick facts

Lead sponsorBurke Medical Research Institute
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposediagnostic
Enrollment27
Start date1 February 2015
Primary completion27 June 2018
Estimated completion31 December 2018
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Burke Medical Research Institute

Who can join

18 and older, any sex, with Healthy or EEG. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this study is to monitor the brain using electroencephalography (EEG) while transcranial direct current stimulation (tDCS) is being administered, as a potential pathway to determine neurophysiological markers capable of forecasting the intensity of a subject's response to tDCS.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Transcranial Direct Current Stimulation

Trials testing the same drug.

Other recruiting trials for Healthy

Currently open trials in the same condition.

Other Burke Medical Research Institute trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03537885.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing